marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Aldeyra Therapeutics Balance Sheet 2011-2024 | ALDX
Annual Balance Sheet Aldeyra Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-129 M | -214 M | -62.8 M | -29.7 M | -47.4 M | -18.7 M | -10.7 M | -13.4 M | -7.27 M | -1.99 M | -791 K | 1.95 M | |
Long Term Debt |
- | 14.9 M | 15.5 M | 11.4 M | 14.5 M | - | 1.22 M | 1.24 M | 1.21 M | 1.18 M | 1.13 M | 266 K | - |
Long Term Debt Current |
239 K | 249 K | 230 K | 233 K | 226 K | - | 116 K | 77.5 K | 77.5 K | 77.5 K | - | - | - |
Total Non Current Liabilities |
- | - | - | 11.4 M | 14.5 M | - | 1.22 M | 1.24 M | 1.21 M | 1.18 M | 1.52 M | 26.8 M | - |
Total Current Liabilities |
22.3 M | 15.4 M | 11.8 M | 12.4 M | 12.9 M | 8.47 M | 3.35 M | 2.3 M | 2.12 M | 1.33 M | - | - | - |
Total Liabilities |
28.5 M | 30.3 M | 27.4 M | 23.8 M | 27.4 M | 8.47 M | 4.57 M | 3.54 M | 3.33 M | 2.5 M | 2.13 M | 27.1 M | 2.59 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-394 M | -357 M | -295 M | -237 M | -199 M | -139 M | -99.6 M | -77.3 M | -58.6 M | -46.5 M | -41.3 M | -54.4 M | -15.5 M |
Total Assets |
148 M | 181 M | 233 M | 83.4 M | 75.5 M | 95.1 M | 44.2 M | 25.2 M | 28.2 M | 8.79 M | 3.74 M | 1.98 M | 259 K |
Cash and Cash Equivalents |
143 M | 144 M | 230 M | 77.9 M | 44.4 M | 47.4 M | 20 M | 12 M | 14.6 M | 8.53 M | 3.26 M | - | - |
Book Value |
120 M | 151 M | 206 M | 59.5 M | 48.1 M | 86.6 M | 39.6 M | 21.6 M | 24.9 M | 6.28 M | 1.61 M | -25.2 M | -2.33 M |
Total Shareholders Equity |
120 M | 151 M | 206 M | 59.5 M | 48.1 M | 86.6 M | 39.6 M | 21.6 M | 24.9 M | 6.28 M | -40.2 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Aldeyra Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
15 M | - | - | - | 2.66 M | 10.1 M | 15 M | 14.9 M | 3.3 M | - | 15.6 M | 15.5 M | 15.4 M | 15.3 M | 10.1 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 16 M | 883 K | 995 K | 1.11 M | 1.22 M | 1.22 M | 1.22 M | 1.22 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 1.21 M | 1.21 M | 1.21 M | 1.21 M | 1.18 M | 1.18 M | 1.18 M | 1.18 M | 1.13 M | 1.13 M | 1.13 M | 1.13 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
32.2 M | 27.7 M | 27.9 M | 28.5 M | 24.3 M | 25.7 M | 31 M | 30.3 M | 27.5 M | - | 32 M | 27.4 M | 27.5 M | 22.7 M | 21.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 8.47 M | 8.47 M | 8.47 M | 8.47 M | 4.57 M | 4.57 M | 4.57 M | 4.57 M | 3.54 M | 3.54 M | 3.54 M | 3.54 M | 3.33 M | 3.33 M | 3.33 M | 3.33 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 5.65 M | 5.65 M | 5.65 M | 5.65 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
6 M | 6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-434 M | -419 M | -402 M | -394 M | -390 M | -381 M | -372 M | -357 M | -344 M | - | -311 M | -295 M | -279 M | -263 M | -248 M | -237 M | -237 M | -237 M | -237 M | -199 M | -199 M | -199 M | -199 M | -139 M | -139 M | -139 M | -139 M | -99.6 M | -99.6 M | -99.6 M | -99.6 M | -77.3 M | -77.3 M | -77.3 M | -77.3 M | -58.6 M | -58.6 M | -58.6 M | -58.6 M | -46.5 M | -46.5 M | -46.5 M | -46.5 M | -41.3 M | -41.3 M | -41.3 M | - | - | - | - | - | - | - | - | - |
Total Assets |
117 M | 126 M | 141 M | 148 M | 147 M | 156 M | 168 M | 181 M | 190 M | - | 223 M | 233 M | 247 M | 256 M | 147 M | 83.4 M | 83.4 M | 83.4 M | 83.4 M | 75.5 M | 75.5 M | 75.5 M | 75.5 M | 95.1 M | 95.1 M | 95.1 M | 95.1 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 8.79 M | 8.79 M | 8.79 M | 8.79 M | 3.74 M | 3.74 M | 3.74 M | 3.74 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
68.1 M | 71 M | 102 M | 143 M | 143 M | 152 M | 165 M | 144 M | 129 M | 121 M | 159 M | 230 M | 241 M | 250 M | 138 M | 77.9 M | 77.9 M | 77.9 M | 77.9 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M | 47.4 M | 47.4 M | 47.4 M | 47.4 M | 20 M | 20 M | 20 M | 20 M | 12 M | 12 M | 12 M | 12 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 8.53 M | 8.53 M | 8.53 M | 8.53 M | 3.26 M | 3.26 M | 3.26 M | 3.26 M | 1.22 M | - | - | - | - | - | - | - |
Book Value |
85.1 M | 98.3 M | 113 M | 120 M | 123 M | 130 M | 137 M | 151 M | 162 M | - | 191 M | 206 M | 220 M | 234 M | 126 M | 59.5 M | 59.5 M | 59.5 M | 59.5 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 86.6 M | 86.6 M | 86.6 M | 86.6 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 21.6 M | 21.6 M | 21.6 M | 21.6 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 6.28 M | 6.28 M | 6.28 M | 6.28 M | -1.9 M | -1.9 M | -1.9 M | -1.9 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
85.1 M | 98.3 M | 113 M | 120 M | 123 M | 130 M | 137 M | 151 M | 162 M | 174 M | 191 M | 206 M | 220 M | 234 M | 126 M | 59.5 M | 59.5 M | 59.5 M | 59.5 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 86.6 M | 86.6 M | 86.6 M | 86.6 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 21.6 M | 21.6 M | 21.6 M | 21.6 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 6.28 M | 6.28 M | 6.28 M | 6.28 M | -40.2 M | -40.2 M | -40.2 M | -40.2 M | -54.4 M | - | - | - | -15.5 M | - | - | - |
All numbers in USD currency